945995343	945995343	CD	B-NP	O
|	|	NN	I-NP	O
KH	KH	NN	I-NP	O
|	|	NN	I-NP	O
44305410	44305410	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1273940	1273940	CD	B-NP	O
|	|	CC	I-NP	O
2/3/2006	2/3/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
FAILURE	FAILURE	NNP	I-NP	O
TO	TO	NNP	I-NP	O
THRIVE	THRIVE	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/19/2006	5/19/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/9/2006	1/9/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
LOZAYA	LOZAYA	NNP	B-NP	O
,	,	,	O	O
RIGOBERTO	RIGOBERTO	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
PRIMARY	PRIMARY	NNP	I-NP	O
CARE	CARE	NNP	I-NP	O
PROVIDER	PROVIDER	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Eddy	Eddy	NNP	I-NP	O
Long	Long	NNP	I-NP	O
Randklev	Randklev	NNP	I-NP	O
Vange	Vange	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Tempe	Tempe	NNP	I-NP	O
Ingnor	Ingnor	NNP	I-NP	O
Lakenavert	Lakenavert	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Metastatic	Metastatic	JJ	B-NP	O
gastric	gastric	JJ	I-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

LIST	LIST	NN	B-NP	O
OF	OF	IN	B-PP	O
OTHER	OTHER	NNP	B-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
AND	AND	CC	O	O
DIAGNOSES	DIAGNOSES	NNP	B-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
in	in	IN	B-PP	O
1992	1992	CD	B-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
CABG	CABG	NN	B-NP	B-protein
of	of	IN	B-PP	O
two	two	CD	B-NP	O
vessels	vessel	NNS	I-NP	O
.	.	.	O	O

Upper	Upper	IN	B-PP	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
gastric	gastric	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
,	,	,	O	O
GERD	GERD	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
buttock	buttock	NN	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
65-year-old	65-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
status	status	NN	I-NP	I-protein
post	post	NN	I-NP	I-protein
MI	MI	NN	I-NP	I-protein
and	and	CC	I-NP	O
CABG	CABG	NN	I-NP	B-protein
,	,	,	O	O
upper	upper	JJ	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
from	from	IN	B-PP	O
gastric	gastric	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
failure	failure	NN	B-NP	O
to	to	TO	B-PP	O
thrive	thrive	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
and	and	CC	O	O
vomiting	vomiting	NN	B-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
most	most	RBS	B-ADVP	O
recently	recently	RB	I-ADVP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
1/26/2006	1/26/2006	CD	B-NP	O
for	for	IN	B-PP	O
upper	upper	JJ	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
gastric	gastric	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
cauterized	cauterize	VBN	I-VP	O
on	on	IN	B-PP	O
EGD	EGD	NN	B-NP	B-protein
during	during	IN	B-PP	O
that	that	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
biopsy	biopsy	NN	I-NP	O
.	.	.	O	O

Unfortunately	Unfortunately	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
iron	iron	NN	B-NP	O
supplementation	supplementation	NN	I-NP	O
,	,	,	O	O
told	tell	VBD	B-VP	O
to	to	TO	I-VP	O
avoid	avoid	VB	I-VP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
alcohol	alcohol	NN	I-NP	O
in	in	IN	B-PP	O
set	set	VBN	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
followup	followup	NN	I-NP	O
EGD	EGD	NN	I-NP	O
in	in	IN	B-PP	O
3	3	CD	B-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
since	since	IN	B-PP	O
then	then	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
persistent	persistent	JJ	B-NP	O
nausea	nausea	NN	I-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
combined	combine	VBN	B-VP	O
with	with	IN	B-PP	O
burping	burping	NN	B-NP	O
and	and	CC	I-NP	O
inability	inability	NN	I-NP	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
p.o.	p.o.	FW	B-NP	O
,	,	,	O	O
especially	especially	RB	B-NP	O
solids	solid	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
vomit	vomit	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
nonbloody	nonbloody	JJ	B-NP	O
yellow	yellow	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
a	a	DT	B-NP	O
20	20	CD	I-NP	O
pound	pound	NN	I-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
two	two	CD	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
describes	describe	VBZ	B-VP	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
epigastric	epigastric	JJ	I-NP	O
discomfort	discomfort	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
more	more	JJR	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
``	``	``	I-NP	O
hunger	hunger	NN	I-NP	O
feeling	feeling	NN	I-NP	O
then	then	RB	B-ADVP	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
pain	pain	NN	I-NP	O
''	''	''	O	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
any	any	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
bowel	bowel	NN	B-NP	O
movements	movement	NNS	I-NP	O
including	include	VBG	B-PP	O
hematochezia	hematochezia	NN	B-NP	O
although	although	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
black	black	JJ	I-NP	O
colored	color	VBN	I-NP	O
stools	stool	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
attributes	attribute	VBZ	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
iron	iron	NN	I-NP	O
supplementation	supplementation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
reports	report	VBZ	B-VP	O
weight	weight	NN	B-NP	O
loss	loss	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
reported	report	VBD	B-VP	O
a	a	DT	B-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
who	who	WP	B-NP	O
sent	send	VBD	B-VP	O
him	him	PRP	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
suspicion	suspicion	NN	I-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
bleeding	bleeding	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
only	only	RB	B-ADVP	O
had	have	VBD	B-VP	O
minimally	minimally	RB	B-NP	O
guaiac	guaiac	JJ	I-NP	O
positive	positive	JJ	I-NP	O
stool	stool	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
hepatic	hepatic	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
inability	inability	NN	B-NP	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
p.o.	p.o.	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
concurrent	concurrent	JJ	I-NP	O
workup	workup	NN	I-NP	O
of	of	IN	B-PP	O
cancer	cancer	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
stable	stable	JJ	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
98.1	98.1	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
of	of	IN	B-PP	O
57	57	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
158/72	158/72	CD	I-NP	O
,	,	,	O	O
respirating	respirate	VBG	B-VP	O
16	16	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
oxygenation	oxygenation	NN	I-NP	O
of	of	IN	B-PP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
flat	flat	JJ	I-NP	O
JVP	JVP	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
sternal	sternal	JJ	I-NP	O
scar	scar	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	B-ADJP	O
obese	obese	JJ	I-ADJP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
mild	mild	JJ	B-NP	O
discomfort	discomfort	NN	I-NP	O
to	to	TO	B-VP	O
deep	deep	VB	I-VP	O
palpation	palpation	NN	B-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
tenderness	tenderness	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
palpable	palpable	JJ	I-NP	O
hepatosplenomegaly	hepatosplenomegaly	NN	I-NP	O
but	but	CC	O	O
questionable	questionable	JJ	B-NP	O
dullness	dullness	NN	I-NP	O
to	to	TO	B-PP	O
percussion	percussion	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
final	final	JJ	I-NP	O
intercostal	intercostal	JJ	I-NP	O
space	space	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	B-cell_line
axillary	axillary	JJ	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

His	His	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
were	be	VBD	B-VP	O
without	without	IN	B-PP	O
edema	edema	NN	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

PERTINENT	PERTINENT	NNP	B-NP	O
LABS	LABS	NNP	I-NP	O
:	:	:	O	O
Chemistry	Chemistry	NNP	B-NP	O
panel	panel	NN	I-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
CBC	CBC	NN	I-NP	B-protein
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
low	low	JJ	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
31.2	31.2	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
LFTs	LFT	NNS	I-NP	B-protein
were	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
mildly	mildly	RB	B-VP	O
elevated	elevate	VBN	I-VP	O
,	,	,	O	O
AST	AST	RB	B-ADVP	O
at	at	IN	B-PP	O
31	31	CD	B-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
right	right	JJ	B-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
hepatic	hepatic	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
SYSTEM	SYSTEM	NN	I-NP	O
:	:	:	O	O
GI/Onc	GI/Onc	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
nausea	nausea	NN	B-NP	O
,	,	,	I-NP	O
vomiting	vomiting	NN	I-NP	O
and	and	CC	I-NP	O
inability	inability	NN	I-NP	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
p.o.	p.o.	FW	B-NP	O
,	,	,	O	O
along	along	IN	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
with	with	IN	B-PP	O
hepatic	hepatic	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
highly	highly	RB	B-ADJP	O
suspicious	suspicious	JJ	I-ADJP	O
of	of	IN	B-PP	O
malignancy	malignancy	NN	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
thus	thus	RB	I-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
inability	inability	NN	B-NP	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
p.o.	p.o.	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
concurrent	concurrent	JJ	I-NP	O
workup	workup	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
hepatic	hepatic	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
for	for	IN	B-PP	O
malignancy	malignancy	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
confirmed	confirm	VBD	B-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
gastric	gastric	JJ	I-NP	O
mass	mass	NN	I-NP	O
and	and	CC	O	O
hepatic	hepatic	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
with	with	IN	B-PP	O
surrounding	surround	VBG	B-VP	O
lymphadenopathy	lymphadenopathy	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
subsequently	subsequently	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
EGD	EGD	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
fungating	fungate	VBG	I-NP	O
mass	mass	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
later	later	RB	I-VP	O
confirmed	confirm	VBN	I-VP	O
on	on	IN	B-PP	O
biopsy	biopsy	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
invasive	invasive	JJ	B-NP	O
adenocarcinoma	adenocarcinoma	NN	I-NP	O
,	,	,	O	O
poorly	poorly	RB	B-VP	O
differentiated	differentiate	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
referred	refer	VBN	I-VP	O
to	to	TO	B-PP	O
oncology	oncology	NN	B-NP	O
who	who	WP	B-NP	O
informed	inform	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
family	family	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
decided	decide	VBD	B-VP	O
to	to	TO	I-VP	O
undergo	undergo	VB	I-VP	O
chemotherapy	chemotherapy	NN	B-NP	O
with	with	IN	B-PP	O
full	full	JJ	B-NP	O
FOX	FOX	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
placed	place	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Port-A-Cath	Port-A-Cath	JJ	I-NP	O
access	access	NN	I-NP	O
on	on	IN	B-PP	O
2/2/2006	2/2/2006	CD	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
received	receive	VBD	B-VP	O
his	his	PRP$	B-NP	O
full	full	JJ	I-NP	O
FOX	FOX	NN	I-NP	O
on	on	IN	B-PP	O
1/9/2006	1/9/2006	CD	B-NP	O
without	without	IN	B-PP	O
incident	incident	NN	B-NP	O
.	.	.	O	O

Throughout	Throughout	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
controlled	control	VBN	I-VP	O
on	on	IN	B-PP	O
antiemetics	antiemetic	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
as	as	IN	B-PP	O
before	before	IN	B-PP	O
NSAIDS	NSAIDS	NN	B-NP	O
and	and	CC	I-NP	O
aspirin	aspirin	NN	I-NP	O
were	be	VBD	B-VP	O
avoided	avoid	VBN	I-VP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
however	however	RB	B-VP	O
given	give	VBN	I-VP	O
his	his	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
bleeding	bleeding	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
closely	closely	RB	I-VP	O
watched	watch	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
for	for	IN	B-PP	O
goal	goal	NN	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
above	above	IN	B-PP	O
28	28	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
only	only	RB	B-ADVP	O
received	receive	VBD	B-VP	O
one	one	CD	B-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
on	on	IN	B-PP	O
1/30/2006	1/30/2006	CD	B-NP	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
an	an	DT	B-NP	O
EGD	EGD	NN	I-NP	B-protein
with	with	IN	B-PP	O
biopsy	biopsy	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
lesion	lesion	NN	I-NP	O
on	on	IN	B-PP	O
1/29/2006	1/29/2006	CD	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
problem	problem	NN	I-NP	O
with	with	IN	B-PP	O
controlling	control	VBG	B-VP	O
his	his	PRP$	B-NP	B-DNA
bleeding	bleed	VBG	I-NP	O
postbiopsy	postbiopsy	NN	I-NP	O
surgery	surgery	NN	I-NP	O
and	and	CC	O	O
interventional	interventional	JJ	B-NP	O
radiology	radiology	NN	I-NP	O
were	be	VBD	B-VP	O
aware	aware	JJ	B-ADJP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
closely	closely	RB	I-VP	O
monitored	monitor	VBN	I-VP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
drop	drop	NN	I-NP	O
.	.	.	O	O

Fortunately	Fortunately	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
any	any	DT	B-NP	O
acute	acute	JJ	I-NP	O
intervention	intervention	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
receive	receive	VB	I-VP	O
some	some	DT	B-NP	O
p.o.	p.o.	FW	I-NP	O
vitamin	vitamin	NN	I-NP	O
K	K	NN	I-NP	O
intermittently	intermittently	RB	B-ADVP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
elevated	elevated	JJ	I-NP	O
INR	INR	NN	I-NP	O
of	of	IN	B-PP	O
1.5	1.5	CD	B-NP	O
.	.	.	O	O

Musculoskeletal	Musculoskeletal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
complain	complain	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
spine	spine	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
says	say	VBZ	B-VP	O
this	this	DT	B-NP	O
pain	pain	NN	I-NP	O
however	however	RB	B-ADVP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
chronic	chronic	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
spinal	spinal	JJ	I-NP	O
MRI	MRI	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
metastatic	metastatic	JJ	B-NP	O
disease	disease	NN	I-NP	O
or	or	CC	O	O
cord	cord	NN	B-NP	O
compression	compression	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
did	do	VBD	B-VP	O
reveal	reveal	VB	I-VP	O
only	only	JJ	B-NP	O
mild	mild	JJ	I-NP	O
degenerative	degenerative	JJ	I-NP	O
joint	joint	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
MI	MI	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
issues	issue	NNS	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
For	For	IN	B-PP	O
his	his	PRP$	B-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
off	off	RP	B-PRT	O
his	his	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
hypoglycemics	hypoglycemic	NNS	I-NP	O
and	and	CC	O	O
put	put	VBN	B-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
insulin	insulin	NN	I-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
standing	standing	NN	I-NP	O
NPH	NPH	NN	I-NP	O
insulin	insulin	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
his	his	PRP$	B-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Vytorin	Vytorin	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
as	as	IN	B-PP	O
separate	separate	JJ	B-NP	O
Zetia	Zetia	NNP	I-NP	O
and	and	CC	I-NP	O
Zocor	Zocor	NNP	I-NP	O
.	.	.	O	O

Fluids	Fluid	NNS	B-NP	O
,	,	,	I-NP	O
electrolytes	electrolyte	NNS	I-NP	O
and	and	CC	I-NP	O
nutrition	nutrition	NN	I-NP	O
:	:	:	O	O
Given	Give	VBN	B-VP	O
his	his	PRP$	B-NP	O
poor	poor	JJ	I-NP	O
inability	inability	NN	I-NP	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
p.o.	p.o.	FW	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
diet	diet	NN	I-NP	O
was	be	VBD	B-VP	O
advanced	advance	VBN	I-VP	O
to	to	TO	B-PP	O
clears	clear	NNS	B-NP	O
and	and	CC	O	O
intermittently	intermittently	RB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
n.p.o.	n.p.o.	RB	B-ADVP	O
for	for	IN	B-PP	O
procedures	procedure	NNS	B-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
bleeding	bleed	VBG	B-VP	O
status	status	NN	B-NP	O
post	post	IN	B-PP	O
his	his	PRP$	B-NP	O
biopsy	biopsy	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
successfully	successfully	RB	I-VP	O
advanced	advance	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Nutrition	Nutrition	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
leave	leave	VB	I-VP	O
recs	rec	NNS	B-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
TPN	TPN	NN	I-NP	O
administration	administration	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
p.o.	p.o.	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
long	long	JJ	I-NP	O
run	run	NN	I-NP	O
however	however	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
doing	do	VBG	I-VP	O
well	well	RB	B-ADVP	O
and	and	CC	O	O
TPN	TPN	NN	B-NP	B-protein
will	will	MD	B-VP	O
be	be	VB	I-VP	O
held	hold	VBN	I-VP	O
off	off	RP	B-PRT	O
for	for	IN	B-PP	O
now	now	RB	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
prophylaxed	prophylaxe	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
PPI	PPI	NN	I-NP	B-protein
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Lovenox	Lovenox	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

Key	Key	NN	B-NP	O
features	feature	NNS	I-NP	O
of	of	IN	B-PP	O
physical	physical	JJ	B-NP	O
exam	exam	NN	I-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
remains	remain	VBZ	B-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
physical	physical	JJ	I-NP	O
exam	exam	NN	I-NP	O
is	be	VBZ	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
AND	AND	CC	O	O
FOLLOW	FOLLOW	NNP	B-NP	O
UP	UP	NNP	I-NP	O
TESTS	TESTS	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
infusion	infusion	NN	I-NP	O
pump	pump	NN	I-NP	O
to	to	TO	B-VP	O
administer	administer	VB	I-VP	O
outpatient	outpatient	NN	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
of	of	IN	B-PP	O
5-FU	5-FU	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
provider	provider	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Rydelek	Rydelek	NNP	I-NP	O
and	and	CC	B-PP	O
as	as	IN	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
his	his	PRP$	B-NP	O
oncologist	oncologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Moyers	Moyers	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
protocol	protocol	NN	I-NP	O
per	per	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Thamphia	Thamphia	NNP	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
p.o.	p.o.	JJ	I-NP	O
intake	intake	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
monitored	monitor	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
potentially	potentially	RB	B-ADVP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
nutrition	nutrition	NN	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
whether	whether	IN	B-SBAR	O
TPN	TPN	NN	B-NP	B-protein
should	should	MD	B-VP	O
be	be	VB	I-VP	O
started	start	VBN	I-VP	O
or	or	CC	O	O
not	not	RB	O	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
antiemetics	antiemetic	NNS	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
pain	pain	NN	I-NP	O
control	control	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
bowel	bowel	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
7-9225279	7-9225279	CD	B-NP	O
HFFocus	HFFocus	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
BLAS	BLAS	NNP	B-NP	O
,	,	,	O	O
JEROMY	JEROMY	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
FALCIONI	FALCIONI	NNP	B-NP	O
,	,	,	O	O
TEDDY	TEDDY	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
1045647	1045647	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
7/12/06	7/12/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/17/06	10/17/06	CD	B-NP	O

